成都蜀西制药

Chengdu Shuxi Pharmaceutical is a Chinese pharmaceutical company headquartered in the Jinniu District of Chengdu, Sichuan Province. Established in 1992, the firm specializes in the research, development, and large-scale production of both chemical pharmaceuticals and traditional Chinese medicine (TCM) preparations. Its product portfolio is diverse, featuring key treatments such as Compound Chondroitin Sulfate for orthopedic health and Ginkgo Biloba extracts for cardiovascular and cerebrovascular conditions. The company operates multiple GMP-certified production lines capable of manufacturing tablets, capsules, and granules. Recognized as a provincial-level high-tech enterprise, Chengdu Shuxi Pharmaceutical maintains a strong presence in the domestic Chinese market through its integrated supply chain. The company continues to focus on the modernization of TCM and the production of essential generic medications.